Trials / Completed
CompletedNCT00757198
Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Kuopio University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Prospective double blind study comparing two remifentanil dosing protocols (0.1 and 0.3 mcg/kg/min) during cardiac surgery. Main outcome measures are postoperative opioid requirements (PCA oxycodone) and postoperative pain (VAS, verbal rating scale).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | remifentanil | remifentanil infusion |
| DRUG | remifentanil | remifentanil infusion |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-12-01
- First posted
- 2008-09-23
- Last updated
- 2013-09-12
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00757198. Inclusion in this directory is not an endorsement.